Anatomic Pathology Market by Product & Service (Instruments (Tissue Processors, Microtome), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal, Lung)), End User, Region - Global Forecasts to 2025

解剖病理学の世界市場予測:製品・サービス別(器具(組織処理装置、ミクロトーム)、消耗品(抗体)、組織病理学)、用途別(疾患診断(癌(胃腸、肺))、エンドユーザー別、地域別

◆タイトル:Anatomic Pathology Market by Product & Service (Instruments (Tissue Processors, Microtome), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal, Lung)), End User, Region - Global Forecasts to 2025
◆商品コード:MD 5104
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年8月28日
◆ページ数:289
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥524,700見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥704,900見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥863,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は解剖病理学の世界市場が2020年333億ドルから2025年468億ドルまで、年平均7.1%成長すると予測しております。本調査レポートでは、解剖病理学の世界市場について詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別(サービス、消耗品、器具)分析、用途別(病気診断、医学研究)分析、エンドユーザー別(病院研究所、臨床検査室、その他)分析、地域別分析、競争状況、企業情報、隣接市場などを含めております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・解剖病理学の世界市場規模:製品・サービス別(サービス、消耗品、器具)
・解剖病理学の世界市場規模:用途別(病気診断、医学研究)
・解剖病理学の世界市場規模:エンドユーザー別(病院研究所、臨床検査室、その他)
・解剖病理学の世界市場規模:地域別
・競争状況
・企業情報
・隣接市場

“Anatomic pathology market to register a CAGR of 7.1% from 2020 to 2025.”
The global anatomic pathology market size is projected to reach a value of USD 46.8 billion by 2025 from USD 33.3 billion in 2020, at a CAGR of 7.1% during the forecast period. The growth in this market is attributed to the high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period. However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper the market growth to a certain extent in the coming years.

“Disease diagnosis segment accounted for the larger share of the anatomic pathology market, by application, in 2019.”
Based on the application, the anatomic pathology market is segmented into disease diagnosis and medical research. In 2019, the disease diagnosis segment accounted for the larger market share, due to the rapid growth in the geriatric population and the increasing incidence of cancer and other chronic diseases.

“Hospital laboratories to register the highest growth in the anatomic pathology market during the forecast period.”
Based on end-users, the anatomic pathology market is segmented into clinical laboratories, hospital laboratories, and other end users. The hospital laboratories segment accounted for the largest market share in 2019 and is projected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to the increasing number of patient visits to hospitals, a growing number of in-house diagnostic procedures performed in hospitals, rising awareness regarding early disease diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.

“North America will continue to dominate the anatomic pathology market during the forecast period”
Geographically, the anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share, followed by Europe. Factors such as the rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the anatomic pathology market in North America.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 36%, Tier 2 – 45%, and Tier 3 – 19%
• By Designation: C-level – 33%, D-level – 40%, and Others – 27%
• By Region: North America – 36%, Europe – 28%, Asia Pacific – 19%, and the Rest of the World – 17%

List of Companies Profiled in the Report
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Danaher Corporation (US)
• Thermo Fisher Scientific (US)
• Hologic, Inc. (US)
• Agilent Technologies (US)
• Becton, Dickinson and Company (US)
• Sakura Finetek (Japan)
• Merck KGaA (Germany)
• Bio SB (US)
• Diapath S.p.A. (Italy)
• BioGenex Laboratories (US)
• Abcam (US)
• Milestone Medical (Italy)
• SLEE medical (Germany)
• Histo-Line Laboratories (Italy)
• Amos Scientific (Australia)
• Jinhua YIDI Medical Appliance Co. Ltd. (China)
• MEDITE GmbH (Germany)
• Cell Signaling Technology (US)
• CellPath (UK)
• Medimeas (India)
• LUPETEC (Brazil)
• Micros Austria (Austria)
• SCILAB Co Ltd (UK)
• Bright Instruments Limited (UK)

Research Coverage:
This report provides a detailed picture of the global anatomic pathology market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall anatomic pathology market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, opportunities, and trends.

【レポートの目次】

1 INTRODUCTION 47
1.1 OBJECTIVES OF THE STUDY 47
1.2 MARKET DEFINITION 47
1.3 MARKET SCOPE 48
1.3.1 MARKETS COVERED 48
FIGURE 1 ANATOMIC PATHOLOGY MARKET SEGMENTATION 48
1.3.2 YEARS CONSIDERED FOR THE STUDY 49
1.4 CURRENCY 49
1.5 LIMITATIONS 49
1.6 STAKEHOLDERS 49

2 RESEARCH METHODOLOGY 50
2.1 RESEARCH DATA 50
FIGURE 2 RESEARCH DESIGN 50
2.1.1 SECONDARY DATA 51
2.1.1.1 Secondary sources 51
2.1.2 PRIMARY DATA 52
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 52
2.2 MARKET SIZE ESTIMATION 52
2.2.1 BOTTOM-UP APPROACH 52
2.2.1.1 Bottom-up approach for the instruments and consumables market 53
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 53
2.2.2 TOP-DOWN APPROACH 53
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 53
2.2.2.1 Services market estimation based on number of tests 54
2.2.2.2 Services market estimation based on procedures 54
2.2.3 GROWTH FORECAST 55
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 55
FIGURE 6 DATA TRIANGULATION METHODOLOGY 55
2.4 ASSUMPTIONS FOR THE STUDY 56

3 EXECUTIVE SUMMARY 57
FIGURE 7 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2020 VS. 2025 (USD MILLION) 57
FIGURE 8 ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2020 VS. 2025 (USD MILLION) 58
FIGURE 9 ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2020 VS. 2025 (USD MILLION) 58
FIGURE 10 ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 59
FIGURE 11 ANATOMIC PATHOLOGY MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 59
FIGURE 12 ANATOMIC PATHOLOGY MARKET, BY REGION 60

4 PREMIUM INSIGHTS 61
4.1 ANATOMIC PATHOLOGY: MARKET OVERVIEW 61
FIGURE 13 HIGH INCIDENCE OF CANCER & OTHER TARGET DISEASES TO DRIVE MARKET GROWTH 61
4.2 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE 62
FIGURE 14 SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN ANATOMIC PATHOLOGY MARKET IN 2019 62
4.3 GEOGRAPHICAL SNAPSHOT OF THE ANATOMIC PATHOLOGY MARKET 63
FIGURE 15 COUNTRIES IN THE ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 63

5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 64
FIGURE 16 ANATOMIC PATHOLOGY MARKET: DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS 64
5.2.1 DRIVERS 64
5.2.1.1 High incidence of cancer and other target diseases 64
TABLE 1 GLOBAL CANCER INCIDENCE, 2018 VS. 2025 65
5.2.1.2 Recommendations for cancer screening 65
5.2.1.3 Availability of reimbursement 65
5.2.1.4 Growing focus on personalized medicine 66
TABLE 2 % OF PERSONALIZED MEDICINES IN OVERALL DRUG APPROVAL BY FDA, 2014 TO 2019 66
5.2.2 OPPORTUNITIES 67
5.2.2.1 Increasing number of clinical trials pertaining to cancer drugs 67
FIGURE 17 NUMBER OF ARTICLES RELATED TO HISTOPATHOLOGY PUBLISHED ON PUBMED (2010–2019) 68
5.2.2.2 Emerging economies 68
5.2.3 CHALLENGES 68
5.2.3.1 Availability of refurbished products 68
5.2.3.2 Lack of skilled professionals 69
TABLE 3 NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018 69
5.2.3.3 Product failures and recalls 69
5.2.4 TRENDS 69
5.2.4.1 Reagent rental agreements 69
5.2.5 IMPACT OF COVID-19 ON THE ANATOMIC PATHOLOGY MARKET 70

6 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE 71
6.1 INTRODUCTION 72
FIGURE 18 SERVICES TO CONTINUE TO DOMINATE THE ANATOMIC PATHOLOGY MARKET DURING THE FORECAST PERIOD 72
TABLE 4 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 72
TABLE 5 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 73
6.2 SERVICES 73
TABLE 6 ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 73
TABLE 7 ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 73
6.2.1 HISTOPATHOLOGY 74
6.2.1.1 The majority of cancers diagnosed are via histopathology—
a key factor driving market growth 74
TABLE 8 HISTOPATHOLOGY SERVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 74
TABLE 9 HISTOPATHOLOGY SERVICES MARKET, BY REGION,
2020–2025 (USD MILLION) 74
6.2.2 CYTOPATHOLOGY 75
6.2.2.1 Government focus on cervical cancer screening has boosted the growth of the cytopathology services market 75
TABLE 10 CYTOPATHOLOGY SERVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 75
TABLE 11 CYTOPATHOLOGY SERVICES MARKET, BY REGION,
2020–2025 (USD MILLION) 75
6.3 CONSUMABLES 76
TABLE 12 ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2019 (USD MILLION) 76
TABLE 13 ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2020–2025 (USD MILLION) 76
6.3.1 ANTIBODIES 77
TABLE 14 ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 77
TABLE 15 ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 77
6.3.1.1 Primary antibodies 77
6.3.1.1.1 North America dominates the primary antibodies market 77
TABLE 16 PRIMARY ANTIBODIES MARKET, BY REGION, 2016–2019 (USD MILLION) 78
TABLE 17 PRIMARY ANTIBODIES MARKET, BY REGION, 2020–2025 (USD MILLION) 78
6.3.1.2 Secondary antibodies 78
6.3.1.2.1 The Asia Pacific region is projected to reach the highest growth for secondary antibodies 78
TABLE 18 SECONDARY ANTIBODIES MARKET, BY REGION, 2016–2019 (USD MILLION) 79
TABLE 19 SECONDARY ANTIBODIES MARKET, BY REGION, 2020–2025 (USD MILLION) 79
6.3.2 KITS & REAGENTS 79
TABLE 20 KITS & REAGENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 80
TABLE 21 KITS & REAGENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 80
6.3.2.1 Stains & solvents 80
6.3.2.1.1 North America accounted for the highest share in this market 80
TABLE 22 STAINS & SOLVENTS MARKET, BY REGION, 2016–2019 (USD MILLION) 81
TABLE 23 STAINS & SOLVENTS MARKET, BY REGION, 2020–2025 (USD MILLION) 81
6.3.2.2 Fixatives 81
6.3.2.2.1 North America accounts for the largest share of the fixatives market 81
TABLE 24 FIXATIVES MARKET, BY REGION, 2016–2019 (USD MILLION) 82
TABLE 25 FIXATIVES MARKET, BY REGION, 2020–2025 (USD MILLION) 82
6.3.2.3 Other kits & reagents 82
TABLE 26 OTHER KITS & REAGENTS MARKET, BY REGION, 2016–2019 (USD MILLION) 82
TABLE 27 OTHER KITS & REAGENTS MARKET, BY REGION, 2020–2025 (USD MILLION) 83
6.3.3 PROBES 83
6.3.3.1 APAC is expected to show the highest growth in the probes market 83
TABLE 28 PROBES MARKET, BY REGION, 2016–2019 (USD MILLION) 83
TABLE 29 PROBES MARKET, BY REGION, 2020–2025 (USD MILLION) 84
6.3.4 OTHER CONSUMABLES 84
TABLE 30 OTHER CONSUMABLES MARKET, BY REGION, 2016–2019 (USD MILLION) 84
TABLE 31 OTHER CONSUMABLES MARKET, BY REGION, 2020–2025 (USD MILLION) 85
6.4 INSTRUMENTS 85
TABLE 32 ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2029 (USD MILLION) 85
TABLE 33 ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY REGION,
2020–2025 (USD MILLION) 86
6.4.1 SLIDE STAINING SYSTEMS 86
6.4.1.1 Availability of automated systems will drive market growth during the forecast period 86
TABLE 34 SLIDE STAINING SYSTEMS MARKET, BY REGION, 2016–2019 (USD MILLION) 87
TABLE 35 SLIDE STAINING SYSTEMS MARKET, BY REGION, 2020–2025 (USD MILLION) 87
6.4.2 TISSUE PROCESSING SYSTEMS 87
6.4.2.1 Rising adoption of automation is a key trend in the tissue processing systems market 87
TABLE 36 TISSUE PROCESSING SYSTEMS MARKET, BY REGION,
2016–2019 (USD MILLION) 88
TABLE 37 TISSUE PROCESSING SYSTEMS MARKET, BY REGION,
2020–2025 (USD MILLION) 88
6.4.3 CELL PROCESSORS 88
6.4.3.1 Cell processors are used to remove unwanted matter in samples—making them important instruments in the market 88
TABLE 38 CELL PROCESSORS MARKET, BY REGION, 2016–2019 (USD MILLION) 89
TABLE 39 CELL PROCESSORS MARKET, BY REGION, 2020–2025 (USD MILLION) 89
6.4.4 MICROTOMES 89
6.4.4.1 North America accounts for the largest share of the microtomes market 89
TABLE 40 MICROTOMES MARKET, BY REGION, 2016–2019 (USD MILLION) 90
TABLE 41 MICROTOMES MARKET, BY REGION, 2020–2025 (USD MILLION) 90
6.4.5 EMBEDDING SYSTEMS 90
6.4.5.1 The Asia Pacific region is expected to register the highest growth during the forecast period for this segment 90
TABLE 42 EMBEDDING SYSTEMS MARKET, BY REGION, 2016–2019 (USD MILLION) 91
TABLE 43 EMBEDDING SYSTEMS MARKET, BY REGION, 2020–2025 (USD MILLION) 91
6.4.6 COVERSLIPPERS 91
6.4.6.1 Coverslippers are widely used instruments in research alongside staining systems 91
TABLE 44 COVERSLIPPERS MARKET, BY REGION, 2016–2019 (USD MILLION) 92
TABLE 45 COVERSLIPPERS MARKET, BY REGION, 2020–2025 (USD MILLION) 92
6.4.7 OTHER INSTRUMENTS 92
TABLE 46 OTHER INSTRUMENTS MARKET, BY REGION, 2016–2019 (USD MILLION) 93
TABLE 47 OTHER INSTRUMENTS MARKET, BY REGION, 2020–2025 (USD MILLION) 93

7 ANATOMIC PATHOLOGY MARKET, BY APPLICATION 94
7.1 INTRODUCTION 95
FIGURE 19 DISEASE DIAGNOSTICS APPLICATIONS TO CONTINUE TO DOMINATE
THE ANATOMIC PATHOLOGY MARKET DURING THE FORECAST PERIOD 95
TABLE 48 ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 95
TABLE 49 ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 95
7.2 DISEASE DIAGNOSTICS 96
TABLE 50 ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
BY DISEASE TYPE, 2016–2019 (USD MILLION) 96
TABLE 51 ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
BY DISEASE TYPE, 2020–2025 (USD MILLION) 96
7.2.1 CANCER 96
TABLE 52 ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2019 (USD MILLION) 97
TABLE 53 ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2020–2025 (USD MILLION) 97
7.2.1.1 Breast cancer 97
7.2.1.1.1 Breast cancer holds the highest mortality rate among cancers in North America 97
TABLE 54 BREAST CANCER INCIDENCE, BY REGION, 2018 VS. 2025 98
TABLE 55 ANATOMIC PATHOLOGY MARKET FOR BREAST CANCER, BY REGION,
2016–2019 (USD MILLION) 98
TABLE 56 ANATOMIC PATHOLOGY MARKET FOR BREAST CANCER, BY REGION,
2020–2025 (USD MILLION) 98

7.2.1.2 Gastrointestinal cancer 99
7.2.1.2.1 North America accounts for the largest share of the anatomic pathology market for gastrointestinal cancer 99
TABLE 57 STOMACH CANCER INCIDENCE, BY REGION, 2018 VS. 2025 99
TABLE 58 ANATOMIC PATHOLOGY MARKET FOR GASTROINTESTINAL CANCER,
BY REGION, 2016–2019 (USD MILLION) 99
TABLE 59 ANATOMIC PATHOLOGY MARKET FOR GASTROINTESTINAL CANCER,
BY REGION, 2020–2025 (USD MILLION) 100
7.2.1.3 Lung cancer 100
7.2.1.3.1 Lung cancer is the most common cancer in the world 100
TABLE 60 LUNG CANCER INCIDENCE, BY REGION, 2018 VS. 2025 100
TABLE 61 ANATOMIC PATHOLOGY MARKET FOR LUNG CANCER, BY REGION,
2016–2019 (USD MILLION) 101
TABLE 62 ANATOMIC PATHOLOGY MARKET FOR LUNG CANCER, BY REGION,
2020–2025 (USD MILLION) 101
7.2.1.4 Prostate cancer 101
7.2.1.4.1 Prostate cancer is the third-leading cause of death in
North America 101
TABLE 63 PROSTATE CANCER INCIDENCE, BY REGION, 2018 VS. 2025 102
TABLE 64 ANATOMIC PATHOLOGY MARKET FOR PROSTATE CANCER, BY REGION, 2016–2019 (USD MILLION) 102
TABLE 65 ANATOMIC PATHOLOGY MARKET FOR PROSTATE CANCER, BY REGION, 2020–2025 (USD MILLION) 102
7.2.1.5 Other cancers 103
TABLE 66 ANATOMIC PATHOLOGY MARKET FOR OTHER CANCER, BY REGION,
2016–2019 (USD MILLION) 103
TABLE 67 ANATOMIC PATHOLOGY MARKET FOR OTHER CANCER, BY REGION,
2020–2025 (USD MILLION) 103
7.2.2 OTHER DISEASES 103
TABLE 68 ANATOMIC PATHOLOGY MARKET FOR OTHER DISEASES, BY REGION,
2016–2019 (USD MILLION) 104
TABLE 69 ANATOMIC PATHOLOGY MARKET FOR OTHER DISEASES, BY REGION,
2020–2025 (USD MILLION) 104
7.3 MEDICAL RESEARCH 104
7.3.1 GROWING RESEARCH ACTIVITIES WILL DRIVE THE ADOPTION OF ANATOMIC PATHOLOGY PRODUCTS IN THIS APPLICATION SEGMENT 104
TABLE 70 ANATOMIC PATHOLOGY MARKET FOR MEDICAL RESEARCH, BY REGION, 2016–2019 (USD MILLION) 105
TABLE 71 ANATOMIC PATHOLOGY MARKET FOR MEDICAL RESEARCH, BY REGION, 2020–2025 (USD MILLION) 105

8 ANATOMIC PATHOLOGY MARKET, BY END USER 106
8.1 INTRODUCTION 107
FIGURE 20 HOSPITAL LABORATORIES TO DOMINATE THE ANATOMIC PATHOLOGY MARKET DURING THE FORECAST PERIOD 107
TABLE 72 ANATOMIC PATHOLOGY MARKET, BY END USER, 2016–2019 (USD MILLION) 107
TABLE 73 ANATOMIC PATHOLOGY MARKET, BY END USER, 2020–2025 (USD MILLION) 108
8.2 HOSPITAL LABORATORIES 108
8.2.1 HOSPITAL LABORATORIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET 108
TABLE 74 ANATOMIC PATHOLOGY MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2016–2019 (USD MILLION) 109
TABLE 75 ANATOMIC PATHOLOGY MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2020–2025 (USD MILLION) 109
8.3 CLINICAL LABORATORIES 109
8.3.1 INCREASING OUTPATIENT SURGERIES TO DRIVE THE GROWTH OF THIS SEGMENT 109
TABLE 76 ANATOMIC PATHOLOGY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2016–2019 (USD MILLION) 110
TABLE 77 ANATOMIC PATHOLOGY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2020–2025 (USD MILLION) 110
8.4 OTHER END USERS 110
TABLE 78 ANATOMIC PATHOLOGY MARKET FOR OTHER END USERS, BY REGION,
2016–2019 (USD MILLION) 111
TABLE 79 ANATOMIC PATHOLOGY MARKET FOR OTHER END USERS, BY REGION,
2020–2025 (USD MILLION) 111

9 ANATOMIC PATHOLOGY MARKET, BY REGION 112
9.1 INTRODUCTION 113
FIGURE 21 NORTH AMERICA WILL CONTINUE TO DOMINATE THE ANATOMIC PATHOLOGY MARKET IN 2025 113
TABLE 80 ANATOMIC PATHOLOGY MARKET, BY REGION, 2016–2019 (USD MILLION) 114
TABLE 81 ANATOMIC PATHOLOGY MARKET, BY REGION, 2020–2025 (USD MILLION) 114
9.2 NORTH AMERICA 115
FIGURE 22 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET SNAPSHOT 115
TABLE 82 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 116
TABLE 83 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 116
TABLE 84 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 116
TABLE 85 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 117
TABLE 86 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016–2019 (USD MILLION) 117
TABLE 87 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020–2025 (USD MILLION) 117
TABLE 88 NORTH AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 118
TABLE 89 NORTH AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 118
TABLE 90 NORTH AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION) 119
TABLE 91 NORTH AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION) 119
TABLE 92 NORTH AMERICA: ANTIBODIES MARKET, BY TYPE,
2016–2019 (USD MILLION) 119
TABLE 93 NORTH AMERICA: ANTIBODIES MARKET, BY TYPE,
2020–2025 (USD MILLION) 120
TABLE 94 NORTH AMERICA: KITS & REAGENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 120
TABLE 95 NORTH AMERICA: KITS & REAGENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 120
TABLE 96 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 121
TABLE 97 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 121
TABLE 98 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2019 (USD MILLION) 121
TABLE 99 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020–2025 (USD MILLION) 122
TABLE 100 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016–2019 (USD MILLION) 122
TABLE 101 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020–2025 (USD MILLION) 122
TABLE 102 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 123
TABLE 103 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 123
9.2.1 US 123
9.2.1.1 The US dominates the global anatomic pathology market 123
TABLE 104 US: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 124
TABLE 105 US: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 124
TABLE 106 US: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 124
TABLE 107 US: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 125
TABLE 108 US: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 125
TABLE 109 US: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 126
TABLE 110 US: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2019 (USD MILLION) 126
TABLE 111 US: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2020–2025 (USD MILLION) 127
TABLE 112 US: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 127
TABLE 113 US: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 127
TABLE 114 US: KITS & REAGENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 128
TABLE 115 US: KITS & REAGENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 128
TABLE 116 US: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 128
TABLE 117 US: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 129
TABLE 118 US: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2019 (USD MILLION) 129
TABLE 119 US: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2020–2025 (USD MILLION) 129
TABLE 120 US: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2019 (USD MILLION) 130
TABLE 121 US: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2020–2025 (USD MILLION) 130
TABLE 122 US: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 130
TABLE 123 US: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 131
FIGURE 23 US: CANCER STATISTICS 131
9.2.2 CANADA 132
9.2.2.1 High burden of cancer to support market growth 132
FIGURE 24 CANADA: CANCER STATISTICS 132
TABLE 124 CANADA: KEY MACROINDICATORS 133
TABLE 125 CANADA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 133
TABLE 126 CANADA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 133
TABLE 127 CANADA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 134
TABLE 128 CANADA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 134
TABLE 129 CANADA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 134
TABLE 130 CANADA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 135
TABLE 131 CANADA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2019 (USD MILLION) 135
TABLE 132 CANADA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2020–2025 (USD MILLION) 136
TABLE 133 CANADA: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 136
TABLE 134 CANADA: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 136
TABLE 135 CANADA: KITS & REAGENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 137
TABLE 136 CANADA: KITS & REAGENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 137
TABLE 137 CANADA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 137
TABLE 138 CANADA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 137
TABLE 139 CANADA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2019 (USD MILLION) 138
TABLE 140 CANADA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020–2025 (USD MILLION) 138
TABLE 141 CANADA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2019 (USD MILLION) 138
TABLE 142 CANADA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2020–2025 (USD MILLION) 139
TABLE 143 CANADA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 139
TABLE 144 CANADA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 139
9.3 EUROPE 140
TABLE 145 EUROPE: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 140
TABLE 146 EUROPE: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 140
TABLE 147 EUROPE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 141
TABLE 148 EUROPE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 141
TABLE 149 EUROPE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 141
TABLE 150 EUROPE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 142
TABLE 151 EUROPE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 142
TABLE 152 EUROPE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 143
TABLE 153 EUROPE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2019 (USD MILLION) 143
TABLE 154 EUROPE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2020–2025 (USD MILLION) 143
TABLE 155 EUROPE: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 144
TABLE 156 EUROPE: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 144
TABLE 157 EUROPE: KITS & REAGENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 144
TABLE 158 EUROPE: KITS & REAGENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 144
TABLE 159 EUROPE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 145
TABLE 160 EUROPE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 145
TABLE 161 EUROPE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2019 (USD MILLION) 145
TABLE 162 EUROPE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020–2025 (USD MILLION) 145
TABLE 163 EUROPE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2019 (USD MILLION) 146
TABLE 164 EUROPE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2020–2025 (USD MILLION) 146
TABLE 165 EUROPE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 146
TABLE 166 EUROPE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 147
9.3.1 GERMANY 147
9.3.1.1 Availability of reimbursement for colorectal cancer screening to support market growth 147
TABLE 167 INCIDENCE OF CANCER, BY TYPE, 2018 VS. 2025 147
TABLE 168 GERMANY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 148
TABLE 169 GERMANY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 148
TABLE 170 GERMANY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 148
TABLE 171 GERMANY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 149
TABLE 172 GERMANY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 149
TABLE 173 GERMANY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 150
TABLE 174 GERMANY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION) 150
TABLE 175 GERMANY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION) 150
TABLE 176 GERMANY: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 151
TABLE 177 GERMANY: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 151
TABLE 178 GERMANY: KITS & REAGENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 151
TABLE 179 GERMANY: KITS & REAGENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 151
TABLE 180 GERMANY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 152
TABLE 181 GERMANY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 152
TABLE 182 GERMANY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2019 (USD MILLION) 152
TABLE 183 GERMANY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020–2025 (USD MILLION) 153
TABLE 184 GERMANY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2019 (USD MILLION) 153
TABLE 185 GERMANY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2020–2025 (USD MILLION) 153
TABLE 186 GERMANY: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 154
TABLE 187 GERMANY: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 154
9.3.2 FRANCE 154
9.3.2.1 Government funding for cancer diagnosis & prevention to support market growth 154
TABLE 188 CANCER INCIDENCE, BY TYPE, 2018 VS. 2025 154
TABLE 189 FRANCE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 155
TABLE 190 FRANCE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 155
TABLE 191 FRANCE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 155
TABLE 192 FRANCE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 156
TABLE 193 FRANCE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 156
TABLE 194 FRANCE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 157
TABLE 195 FRANCE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2019 (USD MILLION) 157
TABLE 196 FRANCE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2020–2025 (USD MILLION) 157
TABLE 197 FRANCE: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 158
TABLE 198 FRANCE: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 158
TABLE 199 FRANCE: KITS & REAGENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 158
TABLE 200 FRANCE: KITS & REAGENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 158
TABLE 201 FRANCE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 159
TABLE 202 FRANCE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 159
TABLE 203 FRANCE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2019 (USD MILLION) 159
TABLE 204 FRANCE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020–2025 (USD MILLION) 159
TABLE 205 FRANCE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2019 (USD MILLION) 160
TABLE 206 FRANCE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2020–2025 (USD MILLION) 160
TABLE 207 FRANCE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 160
TABLE 208 FRANCE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 161
9.3.3 UK 161
9.3.3.1 Government initiatives to drive market growth in the UK 161
TABLE 209 UK: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 162
TABLE 210 UK: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 162
TABLE 211 UK: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 162
TABLE 212 UK: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 163
TABLE 213 UK: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 163
TABLE 214 UK: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 163
TABLE 215 UK: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2019 (USD MILLION) 164
TABLE 216 UK: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2020–2025 (USD MILLION) 164
TABLE 217 UK: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 164
TABLE 218 UK: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 165
TABLE 219 UK: KITS & REAGENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 165
TABLE 220 UK: KITS & REAGENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 165
TABLE 221 UK: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 165
TABLE 222 UK: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 166
TABLE 223 UK: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2019 (USD MILLION) 166
TABLE 224 UK: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2020–2025 (USD MILLION) 166
TABLE 225 UK: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2019 (USD MILLION) 167
TABLE 226 UK: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2020–2025 (USD MILLION) 167
TABLE 227 UK: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 167
TABLE 228 UK: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 168

9.3.4 ITALY 168
9.3.4.1 High incidence of cancer and increasing per capita healthcare spending to support market growth in Italy 168
TABLE 229 INCIDENCE OF CANCER, BY TYPE, 2018 VS. 2025 168
TABLE 230 ITALY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 169
TABLE 231 ITALY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 169
TABLE 232 ITALY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 169
TABLE 233 ITALY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 170
TABLE 234 ITALY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 170
TABLE 235 ITALY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 170
TABLE 236 ITALY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2019 (USD MILLION) 171
TABLE 237 ITALY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2020–2025 (USD MILLION) 171
TABLE 238 ITALY: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 171
TABLE 239 ITALY: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 172
TABLE 240 ITALY: KITS & REAGENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 172
TABLE 241 ITALY: KITS & REAGENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 172
TABLE 242 ITALY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 172
TABLE 243 ITALY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 173
TABLE 244 ITALY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2019 (USD MILLION) 173
TABLE 245 ITALY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2020–2025 (USD MILLION) 173
TABLE 246 ITALY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2019 (USD MILLION) 174
TABLE 247 ITALY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2020–2025 (USD MILLION) 174
TABLE 248 ITALY: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 174
TABLE 249 ITALY: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 175
9.3.5 SPAIN 175
9.3.5.1 High incidence of chronic diseases to drive the Spanish market 175
TABLE 250 SPAIN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 175
TABLE 251 SPAIN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 176
TABLE 252 SPAIN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 176
TABLE 253 SPAIN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 176
TABLE 254 SPAIN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 177
TABLE 255 SPAIN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 177
TABLE 256 SPAIN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2019 (USD MILLION) 178
TABLE 257 SPAIN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2020–2025 (USD MILLION) 178
TABLE 258 SPAIN: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 178
TABLE 259 SPAIN: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 179
TABLE 260 SPAIN: KITS & REAGENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 179
TABLE 261 SPAIN: KITS & REAGENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 179
TABLE 262 SPAIN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 179
TABLE 263 SPAIN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 180
TABLE 264 SPAIN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2019 (USD MILLION) 180
TABLE 265 SPAIN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2020–2025 (USD MILLION) 180
TABLE 266 SPAIN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2019 (USD MILLION) 181
TABLE 267 SPAIN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2020–2025 (USD MILLION) 181
TABLE 268 SPAIN: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 181
TABLE 269 SPAIN: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 182
9.3.6 REST OF EUROPE 182
TABLE 270 ROE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 182
TABLE 271 ROE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 183
TABLE 272 ROE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 183
TABLE 273 ROE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 183
TABLE 274 ROE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 184
TABLE 275 ROE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 184
TABLE 276 ROE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2019 (USD MILLION) 185
TABLE 277 ROE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2020–2025 (USD MILLION) 185
TABLE 278 ROE: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 185
TABLE 279 ROE: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 186
TABLE 280 ROE: KITS & REAGENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 186
TABLE 281 ROE: KITS & REAGENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 186
TABLE 282 ROE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 186
TABLE 283 ROE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 187
TABLE 284 ROE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2019 (USD MILLION) 187
TABLE 285 ROE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2020–2025 (USD MILLION) 187
TABLE 286 ROE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2019 (USD MILLION) 188
TABLE 287 ROE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2020–2025 (USD MILLION) 188
TABLE 288 ROE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 188
TABLE 289 ROE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 189
9.4 ASIA PACIFIC 189
TABLE 290 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 189
TABLE 291 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 190
TABLE 292 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 190
TABLE 293 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 190
TABLE 294 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 191
TABLE 295 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 191
TABLE 296 ASIA PACIFIC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 191
TABLE 297 ASIA PACIFIC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 192
TABLE 298 ASIA PACIFIC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION) 192
TABLE 299 ASIA PACIFIC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION) 192
TABLE 300 ASIA PACIFIC: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 193
TABLE 301 ASIA PACIFIC: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 193
TABLE 302 ASIA PACIFIC: KITS & REAGENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 193
TABLE 303 ASIA PACIFIC: KITS & REAGENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 193
TABLE 304 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 194
TABLE 305 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 194
TABLE 306 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2019 (USD MILLION) 194
TABLE 307 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020–2025 (USD MILLION) 195
TABLE 308 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016–2019 (USD MILLION) 195
TABLE 309 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020–2025 (USD MILLION) 195
TABLE 310 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 196
TABLE 311 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 196
9.4.1 JAPAN 196
9.4.1.1 Presence of a well-developed healthcare system to support market growth in Japan 196
TABLE 312 JAPAN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 197
TABLE 313 JAPAN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 197
TABLE 314 JAPAN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 197
TABLE 315 JAPAN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 198
TABLE 316 JAPAN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 198
TABLE 317 JAPAN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 198
TABLE 318 JAPAN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2019 (USD MILLION) 199
TABLE 319 JAPAN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2020–2025 (USD MILLION) 199
TABLE 320 JAPAN: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 199
TABLE 321 JAPAN: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 200
TABLE 322 JAPAN: KITS & REAGENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 200
TABLE 323 JAPAN: KITS & REAGENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 200
TABLE 324 JAPAN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 200
TABLE 325 JAPAN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 201
TABLE 326 JAPAN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2019 (USD MILLION) 201
TABLE 327 JAPAN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2020–2025 (USD MILLION) 201
TABLE 328 JAPAN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2019 (USD MILLION) 202
TABLE 329 JAPAN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2020–2025 (USD MILLION) 202
TABLE 330 JAPAN: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 202
TABLE 331 JAPAN: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 203
9.4.2 CHINA 203
9.4.2.1 Rising healthcare expenditure to drive the market growth 203
TABLE 332 CHINA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 203
TABLE 333 CHINA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 204
TABLE 334 CHINA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 204
TABLE 335 CHINA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 204
TABLE 336 CHINA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 205
TABLE 337 CHINA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 205
TABLE 338 CHINA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2019 (USD MILLION) 206
TABLE 339 CHINA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2020–2025 (USD MILLION) 206
TABLE 340 CHINA: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 206
TABLE 341 CHINA: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 207
TABLE 342 CHINA: KITS & REAGENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 207
TABLE 343 CHINA: KITS & REAGENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 207
TABLE 344 CHINA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 207
TABLE 345 CHINA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 208
TABLE 346 CHINA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2019 (USD MILLION) 208
TABLE 347 CHINA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2020–2025 (USD MILLION) 208
TABLE 348 CHINA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2019 (USD MILLION) 209
TABLE 349 CHINA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2020–2025 (USD MILLION) 209
TABLE 350 CHINA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 209
TABLE 351 CHINA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 210
9.4.3 INDIA 210
9.4.3.1 Growing healthcare sector in the country to drive market growth 210
TABLE 352 INDIA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 210
TABLE 353 INDIA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 211
TABLE 354 INDIA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 211
TABLE 355 INDIA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 211
TABLE 356 INDIA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 212
TABLE 357 INDIA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 212
TABLE 358 INDIA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2019 (USD MILLION) 213
TABLE 359 INDIA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2020–2025 (USD MILLION) 213
TABLE 360 INDIA: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 213
TABLE 361 INDIA: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 214
TABLE 362 INDIA: KITS & REAGENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 214
TABLE 363 INDIA: KITS & REAGENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 214
TABLE 364 INDIA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 214
TABLE 365 INDIA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 215
TABLE 366 INDIA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2019 (USD MILLION) 215
TABLE 367 INDIA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2020–2025 (USD MILLION) 215
TABLE 368 INDIA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2019 (USD MILLION) 216
TABLE 369 INDIA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2020–2025 (USD MILLION) 216
TABLE 370 INDIA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 216
TABLE 371 INDIA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 217
9.4.4 REST OF ASIA PACIFIC 217
TABLE 372 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 217
TABLE 373 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 218
TABLE 374 ROAPAC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 218
TABLE 375 ROAPAC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 218
TABLE 376 ROAPAC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 219
TABLE 377 ROAPAC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 219
TABLE 378 ROAPAC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2019 (USD MILLION) 220
TABLE 379 ROAPAC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2020–2025 (USD MILLION) 220
TABLE 380 ROAPAC: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 220
TABLE 381 ROAPAC: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 221
TABLE 382 ROAPAC: KITS & REAGENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 221
TABLE 383 ROAPAC: KITS & REAGENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 221
TABLE 384 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 221
TABLE 385 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 222
TABLE 386 ROAPAC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2019 (USD MILLION) 222
TABLE 387 ROAPAC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020–2025 (USD MILLION) 222
TABLE 388 ROAPAC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2019 (USD MILLION) 223
TABLE 389 ROAPAC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2020–2025 (USD MILLION) 223
TABLE 390 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 223
TABLE 391 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 224
9.5 REST OF THE WORLD 224
TABLE 392 ROW: ANATOMIC PATHOLOGY MARKET, BY REGION,
2016–2019 (USD MILLION) 224
TABLE 393 ROW: ANATOMIC PATHOLOGY MARKET, BY REGION,
2020–2025 (USD MILLION) 225
TABLE 394 ROW: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 225
TABLE 395 ROW: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 225
TABLE 396 ROW: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 226
TABLE 397 ROW: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 226
TABLE 398 ROW: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 226
TABLE 399 ROW: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 227
TABLE 400 ROW: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2019 (USD MILLION) 227
TABLE 401 ROW: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2020–2025 (USD MILLION) 227
TABLE 402 ROW: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 228
TABLE 403 ROW: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 228
TABLE 404 ROW: KITS & REAGENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 228
TABLE 405 ROW: KITS & REAGENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 228
TABLE 406 ROW: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 229
TABLE 407 ROW: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 229
TABLE 408 ROW: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2019 (USD MILLION) 229
TABLE 409 ROW: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2020–2025 (USD MILLION) 229
TABLE 410 ROW: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2019 (USD MILLION) 230
TABLE 411 ROW: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2020–2025 (USD MILLION) 230
TABLE 412 ROW: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 230
TABLE 413 ROW: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 231
9.5.1 LATIN AMERICA 231
9.5.1.1 Cancer screening programs to support market growth 231
TABLE 414 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 231
TABLE 415 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 232
TABLE 416 LATIN AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 232
TABLE 417 LATIN AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 232
TABLE 418 LATIN AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 233
TABLE 419 LATIN AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 233
TABLE 420 LATIN AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION) 234
TABLE 421 LATIN AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION) 234
TABLE 422 LATIN AMERICA: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 234
TABLE 423 LATIN AMERICA: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 235
TABLE 424 LATIN AMERICA: KITS & REAGENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 235
TABLE 425 LATIN AMERICA: KITS & REAGENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 235
TABLE 426 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 236
TABLE 427 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 236
TABLE 428 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2019 (USD MILLION) 236
TABLE 429 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020–2025 (USD MILLION) 237
TABLE 430 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016–2019 (USD MILLION) 237
TABLE 431 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020–2025 (USD MILLION) 237
TABLE 432 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 238
TABLE 433 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 238
9.5.2 MIDDLE EAST & AFRICA 238
9.5.2.1 Increasing incidence of cancer in Africa to support market growth 238
TABLE 434 MEA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 239
TABLE 435 MEA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 239
TABLE 436 MEA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 239
TABLE 437 MEA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 240
TABLE 438 MEA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 240
TABLE 439 MEA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2020–2025 (USD MILLION) 240
TABLE 440 MEA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2019 (USD MILLION) 241
TABLE 441 MEA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2020–2025 (USD MILLION) 241
TABLE 442 MEA: ANTIBODIES MARKET, BY TYPE, 2016–2019 (USD MILLION) 241
TABLE 443 MEA: ANTIBODIES MARKET, BY TYPE, 2020–2025 (USD MILLION) 242
TABLE 444 MEA: KITS & REAGENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 242
TABLE 445 MEA: KITS & REAGENTS MARKET, BY TYPE, 2020–2025 (USD MILLION) 242
TABLE 446 MEA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 242
TABLE 447 MEA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 243
TABLE 448 MEA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2019 (USD MILLION) 243
TABLE 449 MEA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2020–2025 (USD MILLION) 243
TABLE 450 MEA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2019 (USD MILLION) 244
TABLE 451 MEA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2020–2025 (USD MILLION) 244
TABLE 452 MEA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2019 (USD MILLION) 244
TABLE 453 MEA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2020–2025 (USD MILLION) 245

10 COMPETITIVE LANDSCAPE 246
10.1 OVERVIEW 246
FIGURE 25 KEY DEVELOPMENTS IN THE ANATOMIC PATHOLOGY MARKET BETWEEN
2017 AND 2020 246
10.2 MARKET SHARE ANALYSIS, 2019 247
FIGURE 26 ANATOMIC PATHOLOGY MARKET SHARE ANALYSIS, BY INSTRUMENT AND CONSUMABLE PROVIDER, 2019 247
10.3 COMPETITIVE SCENARIO 248
10.3.1 AGREEMENTS & PARTNERSHIPS (2017–2020) 248
10.3.2 EXPANSIONS (2017–2020) 248
10.3.3 PRODUCT LAUNCHES & APPROVALS (2017–2020) 249
10.3.4 ACQUISITIONS (2017–2020) 249
10.4 COMPETITIVE LEADERSHIP MAPPING (2019) 249
10.4.1 VENDOR INCLUSION CRITERIA 249
10.4.2 VISIONARY LEADERS 250
10.4.3 INNOVATORS 250
10.4.4 DYNAMIC DIFFERENTIATORS 250
10.4.5 EMERGING COMPANIES 250
FIGURE 27 ANATOMIC PATHOLOGY MARKET COMPETITIVE LEADERSHIP MAPPING 251

11 COMPANY PROFILES 252
(Business overview, Products offered, Recent developments, MNM view)*
11.1 F. HOFFMAN-LA ROCHE LTD. 252
FIGURE 28 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2019) 252
11.2 DANAHER CORPORATION 255
FIGURE 29 DANAHER: COMPANY SNAPSHOT (2019) 255
11.3 PHC HOLDINGS CORPORATION 258
11.4 ABCAM PLC. 260
FIGURE 30 ABCAM PLC.: COMPANY SNAPSHOT (2019) 260
11.5 HOLOGIC, INC. 262
FIGURE 31 HOLOGIC, INC.: COMPANY SNAPSHOT (2019) 262
11.6 AGILENT TECHNOLOGIES 264
FIGURE 32 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019) 264
11.7 BECTON, DICKINSON AND COMPANY 266
FIGURE 33 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019) 266
11.8 SAKURA FINETEK USA INC. 268
11.9 MERCK KGAA 271
FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2019) 271
11.10 BIO SB 273
11.11 BIOGENEX 275
11.12 MILESTONE MEDICAL 277
11.13 HISTO-LINE LABORATORIES 278
11.14 DIAPATH S.P.A. 280
11.15 SLEE MEDICAL GMBH 282
11.16 AMOS SCIENTIFIC PTY LTD 283
11.17 MEDITE MEDICAL GMBH 284
11.18 CELL SIGNALING TECHNOLOGY 285
11.19 CELLPATH LTD. 286
11.20 JINHUA YIDI MEDICAL APPLIANCE CO. LTD 287
11.21 MICROS AUSTRIA 288
11.22 SCILAB CO LTD 289
11.23 LUPETEC 290
11.24 MEDIMEAS 291
11.25 BRIGHT INSTRUMENTS 292
*Business overview, Products offered, Recent developments, , MNM view might not be captured in case of unlisted companies.

12 ADJACENT MARKET 293
12.1 INTRODUCTION 293
12.2 IN VITRO DIAGNOSTICS MARKET 293
12.2.1 MARKET DEFINITION 293
12.2.2 LIMITATIONS 293
12.2.3 MARKET OVERVIEW 293
12.2.3.1 INTRODUCTION 293
12.2.3.2 Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases 294
12.2.3.3 Growing awareness regarding personalized medicine 294
12.3 IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 294
TABLE 454 GLOBAL IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016-2023 (USD MILLION) 295
12.3.1 IN VITRO DIAGNOSTICS MARKET, BY APPLICATION 295
TABLE 455 GLOBAL IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016-2023 (USD MILLION) 295
12.3.2 IN VITRO DIAGNOSTICS MARKET, BY END USER 296
TABLE 456 GLOBAL INVITRO DIAGNOSTICS MARKET, BY END USER,
2016-2023 (USD MILLION) 296
12.4 IN VITRO DIAGNOSTICS MARKET, BY REGION 296
TABLE 457 GLOBAL IN VITRO DIAGNOSTICS MARKET, BY REGION,
2016–2023 (USD MILLION) 297

13 APPENDIX 298
13.1 INSIGHTS FROM INDUSTRY EXPERTS 298
13.2 DISCUSSION GUIDE 299
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 303
13.4 AVAILABLE CUSTOMIZATIONS 305
13.5 RELATED REPORTS 305
13.6 AUTHOR DETAILS 306

★調査レポート[解剖病理学の世界市場予測:製品・サービス別(器具(組織処理装置、ミクロトーム)、消耗品(抗体)、組織病理学)、用途別(疾患診断(癌(胃腸、肺))、エンドユーザー別、地域別] ( Anatomic Pathology Market by Product & Service (Instruments (Tissue Processors, Microtome), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal, Lung)), End User, Region - Global Forecasts to 2025 / MD 5104) 販売に関する免責事項
[解剖病理学の世界市場予測:製品・サービス別(器具(組織処理装置、ミクロトーム)、消耗品(抗体)、組織病理学)、用途別(疾患診断(癌(胃腸、肺))、エンドユーザー別、地域別] ( Anatomic Pathology Market by Product & Service (Instruments (Tissue Processors, Microtome), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal, Lung)), End User, Region - Global Forecasts to 2025 / MD 5104) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆